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doi:10.1016/j.jmii.2012.02.004Background/Purpose(s): Patients receiving hemodialysis infected with methicillin-resistant
Staphylococcus aureus (MRSA) have been considered to have healthcare-associated (HA) infec-
tions, but strains with community-associated (CA) characteristics have also been identified in
this population. The authors compared infections of the two strains among patients with end-
stage renal disease.
Methods: From January 2004 to December 2008 the authors analyzed the demographic and
microbiologic data of 57 patients with community-onset (defined as a positive culture obtained
 48 hours after admission) MRSA bacteremia and end-stage renal disease at a 2900-bed
tertiary medical center. MRSA isolate with staphylococcal cassette chromosome mec (SCCmec)
type II/III was classified as HA strains, and SCCmec type IV/V as CA strains.
Results: Forty-seven patients (82%) had HA-MRSA strains and 10 patients (18%) had CA-MRSA
strains. The major clones of HA-MRSA were sequence type (ST) 5 with SCCmec type II and
staphylococcal protein A (spa) t002 as well as ST239 carrying SCCmec type III and spa t037.
The CA-MRSA strains were predominantly ST59, more susceptible to non-b-lactam antimicro-
bial agents, and had a higher percentage of carrying the Panton-Valentine leukocidin genenfectious Diseases, Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2,
v.tw (F.-D. Wang).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
Community-onset MRSA bacteremia in dialysis patients 97in comparision with the HA-MRSA strains. Patients infected with HA-MRSA isolates had a higher
overall mortality (57.4%, p Z 0.012). In multivariate analysis, male patients were more likely
to be infected with HA-MRSA isolates than CA-MRSA strains (p Z 0.037), and a history of
receiving urinary catheterization within 1 year prior to bacteremia onset (p Z 0.047) is an
independent risk factor to acquiring HA-MRSA strains.
Conclusion: Patients undergoing dialysis and infected with HA-MRSA strains had higher
mortality rates and were more commonly associated with urinary catheterization within 1 year
before bacteremia.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
After methicillin-resistant Staphylococcus aureus (MRSA)
was first documented in Taiwan in the early 1980s, its
prevalence has greatly increased and become an important
nosocomial pathogen.1,2 According to the definition advo-
cated by the Centers for Disease Control and Prevention
(CDC), MRSA infections can be classified as community-
associated (CA) if cultured from patients without estab-
lished risk factors,3 and otherwise as healthcare-associated
(HA). There are many differences between MRSA strains in
these two groups, including pulsed-field gel electrophoresis
(PFGE) patterns, staphylococcal cassette chromosome mec
(SCCmec) type, susceptibility to non-b-lactam antimicro-
bial agents, and the presence of a pore-forming toxin,
Panton-Valentine leukocidin (PVL).4 Compared with HA-
MRSA infections, CA infections are more likely to involve
skin and soft tissues and less likely to involve the res-
piratory tract, urinary tract, or bloodstream.5 HA-MRSA
infections can be further divided into community- or
hospital-onset infections according to the index culture
obtained  or >48 hours after hospital admission.6
Patients with end-stage renal disease (ESRD) undergoing
dialysis are well known to have high rates of infection or
colonization with MRSA,7,8 and the mortality, length of
hospital stay, and healthcare costs are higher among these
patients infected with MRSA than those infected with
methicillin-susceptible S. aureus.9 The MRSA infections in
dialysis-dependent patients were traditionally considered
to be HA, typically with strains carrying SCCmec types II/III
and lacking the gene for the PVL toxin.7 However, this
definition has recently been a matter of debate, because
many HA-MRSA infections are caused by strains with the
CA-MRSA phenotype and characteristics.10 Several reports
in the literature have demonstrated the increasing
percentage of CA-MRSA genotypes among all MRSA isolates
recovered from hospital or HA settings.11e13 Therefore, the
association with the healthcare environment has decreasing
predictive value for distinguishing patients with infections
involving HA-MRSA strains from those with CA-MRSA
isolates.4 Several studies have classified MRSA as HA or
CA strains according to the definition of molecular
phenotype.12e14 In this study, we compared the demo-
graphic characteristics, clinical manifestations, outcomes,
and microbiologic data between infections of CA- and HA-
MRSA strains, classified based on SCCmec phenotype, in
patients with community-onset (CO) MRSA bacteremia who
were undergoing hemodialysis.Materials and methods
Patient selection and data collection
We performed a retrospective study of all adult patients
with ESRD and receiving hemodialysis who had blood
cultures positive for MRSA within 48 hours after admission
at a 2900-bed tertiary medical center in Taiwan from
January 2004 to December 2008. The demographic char-
acteristics, HA risk factors, comorbidities, Charlson
comorbidity index,15 empiric antibiotics therapy regimen,
infection foci, type of vascular access for hemodialysis,
length of hospitalization, and outcomes were reviewed. HA
risk factors were defined as follows: hospitalization,
surgery, colonization of MRSA, residency in a long-term care
facility, and urinary catheterization within 1 year before
bacteremia onset. Colonization was considered whenever
MRSA was recovered from culture of any specimens in the
previous year according to medical record. The probable
focus of infection was assessed on the basis of microbio-
logic and clinical findings. Endovascular lesions included
infection involving vessels such as mycotic aneurysm or
endocarditis diagnosed according to Duke criteria.16
Catheter-related bacteremia was defined by a semi-
quantitative culture of the vascular catheter tip that yiel-
ded more than 15 MRSA colonies in the absence of other
sources of bacteremia.17 Deep-seated infections included
empyema or abscess in the deep-seated organ. Antibiotic
therapy was deemed appropriate if parenteral therapy to
which the organism had documented susceptibility was
initiated within the first 48 hours of obtaining the initial
positive blood culture result.
Microbiologic and molecular characteristics of
isolates
We classified an MRSA isolate as belonging to a CA-MRSA
strain if the SCCmec type IV or V was present and to a HA-
MRSA strain if the SCCmec type II or III was present. Iden-
tification of MRSA was performed using the Vitek II system
(bioMe´rieux, Marcy l’Etoile, France). The bacteria were
then stored at 70C in trypticase soy broth (Difco Labo-
ratories, Le Pont de Claix, France) supplemented with 15%
glycerol before use. Antibiotic susceptibility tests included
ciprofloxacin, clindamycin, daptomycin, gentamicin, levo-
floxacin, linezolid, rifampin, tigecycline, and vancomycin.
Minimal inhibitory concentrations (MICs) were determined
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dilution methods for the other agents according to the
Clinical and Laboratory Standards Institute guidelines.18
The MIC of tigecycline was determined by the agar dilu-
tion method as approved by the Food and Drug Adminis-
tration (Tygacil 2005, tigecycline package insert; Wyeth
Pharmaceuticals, Philadelphia, PA, USA). Determination of
SCCmec type, detection of the genes encoding PVL, and
identification of specific accessory gene regulator (agr),
staphylococcal protein A (spa) were performed using
techniques described elsewhere.19e22 Multilocus sequence
typing was performed for the selected strains of repre-
sentative PFGE patterns with 80% relatedness as described
previously.23
Statistical analysis
Demographic data, risk factors, outcomes, and antibiotic
susceptibility test results were compared. Categoric vari-
ables were compared using the c2 or Fisher exact test, and
numeric variables were expressed as the mean ( standard
deviation) and analyzed by two-sample t-test or Mann-
Whitney U test. Variables with p < 0.1 in the univariate
analysis were entered into the multivariate analysis,
carried out by logistic regression. All analyses were per-
formed using SPSS software version 17.0 (SPSS, Chicago, IL,
USA), and a p value of <0.05 was considered significant for
two-tailed tests.
Results
From January 1, 2004 through December 1, 2008, 57 adult
patients with CO-MRSA bacteremia and ESRD receiving
hemodialysis were included in the study. The main demo-
graphic characteristics of the cohort are listed in Table 1.
Each MRSA isolate was from a unique patient. Of the 57
isolates, 17 (29.8%) were SCCmec II, 30 (52.6%) were
SCCmec III, 6 (10.5%) were SCCmec IV, and 4 (7.0%) were
SCCmec V. The proportion of CA-MRSA isolates increased
from 0% in 2003 to 30.8% in 2007, and decreased to 12.5% in
2008. Univariate analysis indicated that there were more
male patients infected with HA-MRSA strains than with CA-
MRSA strains (51.1% vs. 10%, p Z 0.032). The patients who
had a previous history of surgery within 90 days (68.1% vs.
30%, p Z 0.035) and of receiving urinary catheterization
within 1 year before onset of bacteremia (57.4% vs. 20%,
p Z 0.041) were more likely infected with HA-MRSA strain
than with CA-MRSA strain. The other demographics, clinical
characteristics, and comorbidities were similar in both
groups. In multivariate logistic regression analysis, male sex
(odds ratio Z 11.57, p Z 0.037, [95% confidence interval,
1.16e115.39]) and history of receiving urinary catheteri-
zation within 1 year before onset of bacteremia (odds
ratio Z 6.56, p Z 0.047, [95% confidence interval,
1.03e42.12]) were independent factors associated with HA-
MRSA strain infections (Table 2).
For infection foci, catheter-related infections were the
most common identified source, followed by pneumonia
and skin and soft-tissue infections, with 34, 11, and 7
isolates, respectively; however, there was no statistically
significant difference between the two groups (Table 3).The patients infected with HA-MRSA strains had a higher
overall mortality (57.4% vs. 10%, p Z 0.012), despite
similar length of hospitalization and mortality within 7
days and 30 days after admission between the two groups
(Table 3).
The molecular characteristics of the isolates are pre-
sented in Table 4, and the PFGE results of the MRSA isolates
containing the four different SCCmec types are shown in
Fig. 1. The major pulsotypes carrying SCCmec type II were
ST5, spa t002 (65%), and agr II (94.1%). The main isolates
with SCCmec type III were ST 239, spa t037 (77%), and agr I
(100%). The 10 CA-MRSA strains harboring SCCmec type IV/V
were heterogeneous in spa type and were predominantly
ST59 and agr I (70%). No HA-MRSA isolates carried the PVL
gene, and three CA-MRSA isolates (30%) carried the PVL
gene (p Z 0.04). For antimicrobial susceptibility (Table 5),
the HA-MRSA strains were more resistant to clindamycin,
ciprofloxacin, gentamicin, and levofloxacin (all p < 0.05).
Although no significantly different vancomycin-susceptible
rate (defined as MIC  1 mg/L) between the two groups
(p Z 0.184) was observed, a higher MIC was found in the
HA-MRSA isolates.Discussion
MRSA infections in dialysis-dependent patients have been
considered to be HA according to epidemiologic classifica-
tion, but recent research has found that MRSA strains
harboring SCCmec types IV/V, which are predominantly
present in CA infections, are also responsible for HA
infections or colonization in these patients.7,8,14,24 In our
investigation, an increasing frequency of CA-MRSA strains
infections is noted during the study period, similar to the
results of other reports.12e14,24 The acquisition of CA-MRSA
strains may have occurred either at home or from health-
care contact, as there is a rising proportion of MRSA
infections caused by CA-MRSA strains in the healthcare
setting.7
The patients in our study infected with CA-MRSA strains
were predominantly female (9 of 10, 90%). There were
more female patients (nZ 12, 75%) with ESRD colonized by
MRSA carrying SCCmec type II in the study by Johnson et al.7
but no significant difference in sex distribution in the report
by Lin et al.14 Few data are available about the relationship
between the presence of MRSA strains with different
SCCmec types and urinary catheterization within 1 year
before MRSA bacteremia, which is a risk factor for acqui-
sition of HA-MRSA strains in our study. In previous research
of MRSA infection in critically ill patients,25 patients
receiving urinary catheterization within 7 days prior to
acquisition of MRSA were more likely to acquire HA strains
than CA strains with an insignificant difference. A recent
study by Lin et al.14 demonstrated that a longer duration of
dialysis was an independent factor for infection with CA-
MRSA strains. Nevertheless, there was no significant
difference in duration of dialysis between the two groups in
our study.
Previous studies have revealed infections with CA-MRSA
strains are more likely to be skin and soft-tissue infections,
osteomyelitis, and joint infections, whereas blood-
stream infections are more common among HA-MRSA
Table 1 Demographic and clinical characteristics of healthcare-associated and community-associated methicillin-resistant
Staphylococcus aureus strains in patients with community-onset bacteremia and end-stage renal disease
Variable, n (%) HA-MRSA CA-MRSA p
No. 47 (82.5%) 10 (17.5%)
Age, mean  SD, years 70.9  13.2 72.6  10.3 0.712
Male 24 (51.1) 1 (10) 0.032
Underlying diseases
Alcoholism 5 (10.6) 0 (0) 0.574
Cerebrovascular disease 9 (19.1) 2 (20) >0.999
Congestive heart failure 10 (21.3) 3 (30) 0.680
Coronary artery disease 10 (21.3) 0 (0) 0.182
Chronic obstructive pulmonary disease 10 (21.3) 0 (0) 0.182
Charlson comorbidity index, mean  SD 5.9  2.6 5.4  3.1 0.578
Diabetes mellitus 30 (63.8) 5 (50) 0.485
Hypertension 31 (66.0) 7 (70) >0.999
Liver cirrhosis 1 (2.1) 0 (0) >0.999
Malignancy 10 (21.3) 2 (20) >0.999
Operation within 90 days before bacteremia 32 (68.1) 3 (30) 0.035
Current smoker 10 (21.3) 0 (0) 0.182
Duration of hemodialysis before bacteremia, months
Mean  SD 24.96  33.76 12.19  15.71 0.250
Median (interquartile range) 13 (2.2-3.6) 9 (3.35-12.75) 0.367
Vascular access at the time of admissiona
Graft (synthetic conduit) 2 (4.3) 1 (10) 0.446
Tunneled catheter 23 (48.9) 4 (40) 0.734
Fistula (natural vessel) 15 (31.9) 4 (40) 0.717
Temporary catheter 14 (29.8) 2 (20) 0.708
Year of isolation
2004 10 (100) 0 (0)
2005 14 (87.5) 2 (12.5)
2006 7 (70) 3 (30)
2007 9 (69.2) 4 (30.8)
2008 7 (87.5) 1 (12.5)
HA risk factor within 1 year before bacteremia
Colonization of MRSAb 20 (42.6) 1 (10) 0.074
Hospitalization 46 (97.9) 9 (90) 0.323
Residency in a long-term care facility 10 (21.3) 2 (20) >0.999
Surgery 39 (80.9) 7 (70) 0.424
Urinary catheterization 27 (57.4) 2 (20) 0.041
a Numbers may sum to more than 100% because patients could have multiple hemodialysis access sites.
b Colonization was considered whenever MRSA was recovered from culture of any specimens in the previous year.
CA Z community-associated; HA Z healthcare-associated; MRSA Z methicillin-resistant Staphylococcus aureus; SD Z standard
deviation.
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our study, and catheter-related infections were the most
common infection focus, probably because our patients all
receive dialysis.
In the previous two reports of MRSA infection among
dialysis population,8,14 the groups with CA-MRSA infec-
tions and with HA-MRSA infections had similar mortality
rates. Nevertheless, the patients with CA-MRSA infections
in our investigation had a significant lower overall
mortality than those with HA-MRSA infections, despite no
significant difference in 7- and 30-day mortality.
In Taiwan, the most prevalent HA-MRSA strains are ST239
carrying SCCmec type III, and these account forapproximately half of the HA infections.11,28,29 MRSA ST5
with SCCmec type II is an epidemic clone, spreading
through Japan, the United States, and Europe, and has
demonstrated an increased prevalence in Taiwan.1,2,11 The
two strains were also the predominant clones in our
investigation, which was comparable with a previous
study.11 The ST59 strain with SCCmec type IV/PVL-negative
or with SCCmec type V/PVL-positive is the major CA-MRSA
clone in Taiwan and the second most common MRSA
clone.1,14,28,30 This clone primarily causes CA infections in
Taiwan, but HA infections have also been reported.2,29
MRSA ST59 accounted for 10% (6 of 57) of the infections in
our investigation, much lower than the rate of 76% reported
Table 3 Infection foci and outcome for healthcare-associated and community-associated methicillin-resistant Staphylococcus
aureus strains in patients with community-onset bacteremia and end-stage renal disease
Variable, n (%) SCCmec types p
HA-MRSA (nZ47) CA-MRSA (nZ10)
Infection focia
Primary bacteremia 5 (10.6) 0 (0) 0.574
Skin and soft tissue infection 6 (12.8) 1 (10) >0.999
Catheter-related infection 26 (55.3) 8 (80) 0.178
Bone and joint infection 2 (4.3) 0 (0) >0.999
Pneumonia 10 (21.3) 1 (10) 0.668
Infective endocarditis 3 (6.4) 0 (0) >0.999
Surgical site infection 1 (2.1) 2 (20) >0.999
Urinary tract infection 1 (2.1) 1(10) 0.323
Deep seated abscess 5 (10.6) 0 (0) 0.574
Appropriate empirical antibiotics 24 (51.1) 6 (60) 0.869
Intravascular catheter/device removal
after bacteremia onset
20 (42.6) 5 (50) 0.936
Outcome
Length of hospital stay, mean  SD 29.7  30.3 38.4  49.5 0.467
7-day mortality 10 (21.3) 0 (0) 0.182
30-day mortality 19 (40.4) 1 (10) 0.082
Overall mortality 27 (57.4) 1 (10) 0.012
a Patients may have more than one focus.
CA Z community-associated; HA Z healthcare-associated; MRSA Z methicillin-resistant Staphylococcus aureus;
SCCmec Z staphylococcal cassette chromosome mec; SD Z standard deviation.
Table 2 Results of multivariate logistic regression analyses of factors associated with hospital-associated methicillin-resistant
Staphylococcus aureus strains in patients with community-onset bacteremia and end-stage renal disease
Variable Odds ratio 95% confidence interval p
Colonization within 1 year before admission 2.57 0.24e27.10 0.432
Operation within 90 days before admission 2.98 0.53e16.68 0.214
Male 11.57 1.16e115.39 0.037
Urinary catheter within 1 year before admission 6.56 1.03e42.12 0.047
100 H.-S. Wu et al.by Huang et al.29 Different study populations and periods
might explain this discrepancy, whereas both reports have
revealed the spread of CA-MRSA strains into the hospital
setting. In the current study, CA-MRSA strains were more
susceptible to non-b-lactam antimicrobial agents, similar to
the results of previous reports.5,8,11 Despite both groups
being susceptible to vancomycin, the proportion of the HA-Table 4 Molecular typing and virulence genes of methicillin-re
Characteristic
II III
No. 17 30
MLST of major pulsotype ST5 ST2
spa (%) T002 (65) t03
Major agr type (%) agr2 (94.1) agr
PVL (%) 0 (0) 0 (0
a The spa types of the four isolates were different to each other an
agr Z accessory gene regulator; MLST Z multilocus sequence typing
cassette chromosome mec; spa Z staphylococcal protein A.MRSA strains displaying a vancomycin MIC >1 mg/L is
slightly higher than that of CA-MRSA clones without
a significant difference. It has been reported that CA-MRSA
isolates possess lower MICs to vancomycin than HA
strains.11 Although CA-MRSA strains were more susceptible
to clindamycin than HA strains with statistical significance,
the resistant rates of both strains were high.sistant Staphylococcus aureus with different SCCmec types
SCCmec types
IV V
6 4
39 ST59 ST59
7 (77) t437(50), t3525(50) NAa
1 (100) agr1 (66) agr1 (75)
) 0 (0) 3 (75)
d were t3525, t2755, t441, and t437 respectively.
; PVL Z Panton-Valentine leukocidin; SCCmec Z staphylococcal
Figure 1. Pulsed-field gel electrophoresis of healthcare-associated and community-associated methicillin-resistant Staphylo-
coccus aureus strains. SCCmec Z staphylococcal cassette chromosome mec; spa Z staphylococcal protein A; MLST Z multilocus
sequence typing; agr Z accessory gene regulator.
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Table 5 Antimicrobial susceptibility of healthcare-
associated and community-associated methicillin-resistant
Staphylococcus aureus strains
HA-MRSA CA-MRSA p
Antimicrobial susceptible rate (%)
Ciprofloxacin 0 (0) 10 (100) <0.01
Clindamycin 1 (2.1) 3 (30) 0.015
Daptomycin 47 (100) 10 (100)
Gentamicin 1 (2.1) 6 (60) <0.01
Levofloxacin 0 (0) 10 (100) <0.01
Linezolid 47 (100) 10 (100)
Rifampin 45 (95.7) 10 (100) >0.999
Tigecycline 47 (100) 10 (100)
Vancomycin 47 (100) 10 (100)
Vancomycin (MIC  1) 38 (80.9) 10 (100) 0.336
CA Z community-associated; HA Z healthcare-associated;
MIC Z minimal inhibitory concentration; MRSA Z methicillin-
resistant Staphylococcus aureus.
102 H.-S. Wu et al.Our investigation had certain limitations. First, the study
was retrospective, based on chart review, and information
bias might have been introduced. Second, the compre-
hensive medical managements were not recorded in our
studies. Thus, the difference in outcome might be influ-
enced by factors other than SCCmec phenotype.
With the encroachment of CA-MRSA strains into the
healthcare setting, the creation of a category of patients
who have CA-strain-related CO-MRSA bacteremia with
standard definitions would allow improved categorization
of the patients with ESRD in future studies. There were
more females infected with MRSA carrying SCCmec type IV/
V, and MRSA harboring type II/III was found more frequently
in patients with previous urinary catheterization, surgery,
and associated higher mortality. Further prospective
studies with larger samples might be needed to confirm
these results.Acknowledgments
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